{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T19:47:25Z","timestamp":1791488845937,"version":"4.3.4"},"reference-count":12,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"7","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2012,7]]},"DOI":"10.1097\/inf.0b013e3182575e6a","type":"journal-article","created":{"date-parts":[[2012,4,5]],"date-time":"2012-04-05T05:51:27Z","timestamp":1333605087000},"page":"771-773","source":"Crossref","is-referenced-by-count":24,"title":["Use of Pentoxifylline in Treatment of Children With Dengue Hemorrhagic Fever"],"prefix":"10.1097","volume":"31","author":[{"given":"Doris","family":"Salgado","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatiana Esther","family":"Zabaleta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven","family":"Hatch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta Rocio","family":"Vega","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jairo","family":"Rodriguez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-27-20210202","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1590\/S0124-00642007000100006","article-title":"Clinical and epidemiological characterisation of dengue haemorrhagic fever in Neiva, Colombia, 2004.","volume":"9","author":"Salgado","year":"2007","journal-title":"Rev Salud Publica (Bogota)"},{"key":"R2-27-20210202","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1086\/314680","article-title":"Early immune activation in acute dengue illness is related to development of plasma leakage and disease severity.","volume":"179","author":"Green","year":"1999","journal-title":"J Infect Dis"},{"key":"R3-27-20210202","doi-asserted-by":"crossref","first-page":"2676","DOI":"10.4049\/jimmunol.175.4.2676","article-title":"Altered cytokine responses of dengue-specific CD4 T cells to heterologous serotypes.","volume":"175","author":"Mangada","year":"2005","journal-title":"J Immunol"},{"key":"R4-27-20210202","first-page":"159","article-title":"The haemorheological and antithrombotic potential of pentoxifylline (Trental): a review.","volume":"5","author":"Schonharting","year":"1988","journal-title":"Pharmatherapeutica"},{"key":"R5-27-20210202","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1111\/j.1574-695X.2003.tb00646.x","article-title":"Anti-TNF antibody treatment reduces mortality in experimental dengue virus infection.","volume":"35","author":"Atrasheuskaya","year":"2003","journal-title":"FEMS Immunol Med Microbiol"},{"key":"R6-27-20210202","doi-asserted-by":"crossref","first-page":"50","DOI":"10.2165\/00003495-198734010-00003","article-title":"Pentoxifylline. A review of its pharmacodynamic and pharmacokinetic properties, and its therapeutic efficacy.","volume":"34","author":"Ward","year":"1987","journal-title":"Drugs"},{"key":"R7-27-20210202","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1097\/01.TA.0000096642.54111.E8","article-title":"Effects of phosphodiesterase inhibition on the inflammatory response after shock: role of pentoxifylline.","volume":"56","author":"Coimbra","year":"2004","journal-title":"J Trauma"},{"key":"R8-27-20210202","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1111\/1523-1747.ep12499916","article-title":"Pentoxifylline inhibits certain constitutive and tumor necrosis factor-alpha-induced activities of human normal dermal fibroblasts.","volume":"98","author":"Berman","year":"1992","journal-title":"J Invest Dermatol"},{"key":"R9-27-20210202","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1111\/j.1365-2710.2009.01077.x","article-title":"Effects of pentoxifylline on coagulation profile and disseminated intravascular coagulation incidence in Egyptian septic neonates.","volume":"35","author":"Adel","year":"2010","journal-title":"J Clin Pharm Ther"},{"key":"R10-27-20210202","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1097\/00003246-199904000-00042","article-title":"Effect of the immunomodulating agent, pentoxifylline, in the treatment of sepsis in prematurely delivered infants: a placebo-controlled, double-blind trial.","volume":"27","author":"Lauterbach","year":"1999","journal-title":"Crit Care Med"},{"key":"R11-27-20210202","doi-asserted-by":"crossref","first-page":"825","DOI":"10.3109\/0886022X.2010.494800","article-title":"Seasonal variation of C-reactive protein and atherosclerotic cardiovascular events in hemodialysis patients.","volume":"32","author":"Balaforlu","year":"2010","journal-title":"Ren Fail"},{"key":"R12-27-20210202","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1080\/00365540903127417","article-title":"The time course of body temperature, serum amyloid A protein, C-reactive protein and interleukin-6 in patients with bacterial infection during the initial 3 days of antibiotic therapy.","volume":"41","author":"Lannergard","year":"2009","journal-title":"Scand J Infect Dis"}],"container-title":["Pediatric Infectious Disease Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00006454-201207000-00027","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T20:42:20Z","timestamp":1786048940000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00006454-201207000-00027"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,7]]},"references-count":12,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2012]]}},"URL":"https:\/\/doi.org\/10.1097\/inf.0b013e3182575e6a","relation":{},"ISSN":["0891-3668"],"issn-type":[{"value":"0891-3668","type":"print"}],"subject":[],"published":{"date-parts":[[2012,7]]}}}